RECK and neoplasm: Subsequently, RECK was screened as a tumor-related candidate gene using multiple bioinformatics strategies with the criterion of P < 0.05, including correlation analysis for clinical characteristic relevance, survival analysis, and receiver operating characteristic curve (ROC) analysis.